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Abstract
Structural and biophysical studies of protein complexes require multi-milligram quantities of soluble material. Subunits are
often unstable when expressed separately so co-expression strategies are commonly employed since in vivo complex
formation can provide stabilising effects. Defining constructs for subunit co-expression experiments is difficult if the
proteins are poorly understood. Even more problematic is when subunit polypeptide chains co-fold since individually they
do not have predictable domains. We have developed CoESPRIT, a modified version of the ESPRIT random library construct
screen used previously on single proteins, to express soluble protein complexes. A random library of target constructs is
screened against a fixed bait protein to identify stable complexes. In a proof-of-principle study, C-terminal fragments of the
influenza polymerase PB2 subunit containing folded domains were isolated using importin alpha as bait. Separately, a C-
terminal fragment of the PB1 subunit was used as bait to trap N-terminal fragments of PB2 resulting in co-folded complexes.
Subsequent expression of the target protein without the bait indicates whether the target is independently stable, or co-
folds with its partner. This highly automated method provides an efficient strategy for obtaining recombinant protein
complexes at yields compatible with structural, biophysical and functional studies.
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Introduction
Many proteins do not function as monomers in the cell, but
interact with partners in stable or transient complexes. Therefore,
to understand their function, characterisation of subcomplexes of
multi-component entities is necessary [1–4]. Characterisation of
protein complexes has received considerable attention in the post-
genomic era and large scale experimental and bioinformatic
studies have identified the subunit content of many protein
complexes. These subunits exist in a continuum from completely
unstructured proteins that fold upon binding to those that fold
individually and subsequently dock together [5–10]. Although the
components of many protein complexes have been catalogued
using proteomics methods (e.g. [11]), recombinant expression of
intact complexes for structural studies remains a major challenge.
In particular, careful experimental validation of complexes
predicted from high throughput studies is necessary to filter out
transient, unstable or non-existent complexes prior to commence-
ment of recombinant expression trials [12].
A common strategy for obtaining protein complexes is to
express single proteins separately and then reconstitute complexes
from purified components. Various experimental approaches for
assembling protein complexes under in vitro conditions have been
developed [13–15]. Although these methods can be efficient, the
formation of protein complexes is dependent on soluble expression
of each component. In many cases when heterologous expression
systems are employed, complex subunits cannot fold in the
absence of their partners and so co-expression strategies are
employed to produce subunits in the same host cell [16,17]. Co-
expression facilitates soluble complex formation by allowing co-
folding or stabilisation through binding of protein partners. This
can reduce or prevent aggregation or degradation, and alleviates
the need for in vitro purification and reconstitution [18]. Several
studies have revealed how co-expression can perform better than
reconstitution from separately purified components [4,19].
Among various systems to produce heterologous proteins for
structural and functional studies, protein expression in Escherichia
coli is the most commonly used system because it is genetically
simple, inexpensive for producing large quantities of proteins and
permits the isotopic or heavy atom labelling of proteins that is
necessary for some structural methods. However, when full-length
eukaryotic proteins are produced in E. coli, aggregation and
insolubility problems often arise resulting in low yields [20].
Contributing factors include large size, susceptibility to proteases,
intrinsic segmental flexibility or requirements for post-translational
modifications. In fields such as structural biology, expression of
more stable sub-full-length protein constructs is a common
strategy, but this necessitates prediction of domain boundaries in
order to design constructs. Multiple sequence alignments are the
most common tool for domain prediction and are used to guide
subsequent trial-and-error PCR subcloning experiments. One
problem with this approach is that many proteins are poorly
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others, precluding this approach. In these cases secondary
structure predictions and order/disorder predictors can help
identify folded domains. Several convenient meta server tools
exist that combine different secondary structure and order
predictors with additional information sources to provide more
accurate domain predictions and even associated automated
primer design, for example ProteinCCD [21] and the SGC
Domain Boundary Analyser [22]. Such tools can be very valuable,
but do not always result in successful expression, in part because
they are generally low resolution and even small variations at the
edges of construct can affect the level of expression and stability of
the products in an unpredictable manner.
For such problematic targets, a number of random library-based
strategies have been developed that generate large collections of
randomly truncated or fragmented constructs and couple these to a
screen or selection process to identify rare soluble clones [23–28]
reviewed in [29–31]. The ESPRIT technology developed in our
laboratory uses exonuclease III/mung bean nuclease protocols [32]
to generate unidirectionally or bidirectionally truncated construct
libraries. Tens of thousands of clones can then be screened in a
colony array format using efficiency of in vivo biotinylation of a fused
biotin acceptor peptide to enrich soluble clones from the library
[28]. Positive clones are then further validated in 96 well plates by
automated affinity chromatography purification [33]. ESPRIT has
been used to express a number of challenging proteins for further
structural study [27,34–39].
There has been no detailed description of library methods being
used to express protein complexes directly i.e. incorporating co-
expression approaches. Here, we have established a high-through-
put automated strategy in which a library of constructs is screened
for solubility in the presence of an interacting bait protein. As such,
it is similar in concept to two-hybrid methods but in the context of
recombinant over-expression of multi-milligram quantities of
material required for many downstream applications including
structural biology and vaccine research. Soluble protein complexes
identified by this method can either result from association of pre-
folded partners or inter-folded polypeptide chains. To demonstrate
the isolation of both types of complexes, we used subunits from the
heterotrimeric influenza RNA polymerase that comprises three
subunits: PA, PB1 and PB2. This complex catalyses the transcrip-
tion and replication of the viral RNA genome in the nucleus of
infected cells [40]. The PB2 subunit has been shown to interact with
importin a to achieve nuclear localisation [27]. For many years the
polymerase subunits resisted all attempts at soluble recombinant
expression due their relatively large sizes (PA: 716 aa; PB1: 757aa;
PB2: 759aa) and their lack of homology with other proteins which
prevented domain identification using multiple sequence align-
ments. The PB2 subunit was previously studied using the ESPRIT
method leading to the expression and subsequent structure solution
ofaseriesofnoveldomainskeytoviralfunction[27,37,39]reviewed
in [41,42].
Here we screened PB2 gene libraries against bait proteins with
the aim of isolating purifiable complexes. Firstly a 59 truncation
library of the gene encoding the polymerase PB2 subunit was
screened against importin a1 that has been shown to bind the
purified C terminus of PB2 when mixed in vitro [39]. Secondly a 39
truncation library of the same subunit was screened against a
poorly behaving, marginally soluble C-terminal construct isolated
from the PB1 polymerase subunit in an earlier ESPRIT
experiment (data not shown). A similar PB1 construct was recently
shown by X-ray crystallography to form an inter-folded complex
with a short N-terminal fragment of PB2 [43], explaining its poor
behaviour in isolation. In both experiments, a series of soluble
complexes were isolated, some of which were similar to
structurally validated forms, while others may be of potential
interest in future functional studies.
The application of ESPRIT in this co-expression format
(CoESPRIT) provides a powerful way of identifying well-
expressing soluble complexes for in vitro and in vivo biochemical
and structural characterisation, as well as immunisation, high
throughput screening and other applications that require multi-
milligram quantities of material. Additionally the same format has
the potential for co-expression of other interacting proteins such as
chaperones and modifying enzymes, widening the repertoire of
expression tools for obtaining sufficient quantities of purified
protein complexes.
Results
Design of a plasmid system allowing library construction
and bait co-expression
The plasmids used for library construction are pET9a derived,
encoding the PB2 gene fused to either 59 hexahistidine tag or 39
biotin acceptor peptide coding sequences with, in each case, the
other tag present out-of-frame at the opposing end and separated
from the coding sequence by a pair of restriction sites enabling
unidirectional truncation [32]. The plasmid pYAN008 for N-
terminal truncation libraries encodes an in-frame fusion of biotin
acceptor peptide and an out-of-frame fusion of the hexahistidine
tag sequence with the PB2 gene; while the plasmid pYAN009 for
C-terminal truncation libraries encodes an out-of-frame fusion of
biotin acceptor peptide and an in-frame fusion of the hexahistidine
tag sequence with the PB2 gene (Fig. S1A). Following the
exonuclease III deletion procedure and religation, one third of
plasmid constructs encode the PB2 insert in-frame with both N-
and C-terminal tags.
The co-expression vector for the fixed bait protein contains
several key features (Fig. S1B). Firstly the RIL plasmid provides
replicative compatibility with the pET library vector and
supplements rare tRNAs. Secondly, a T7 expression cassette was
introduced previously (see methods) resulting in a vector, pLIC-
SGC1, for co-expression purposes. The advantage of using two
separate plasmids is that one library can be screened against
multiple baits in parallel, as performed here when the PB2 C-
terminal truncation library was analysed for interaction with three
different C-terminal constructs of its partner PB1. Thirdly, a
FLAG tag fused to the N terminus of the bait (importin a1 or PB1
C-terminal sub-constructs) permits its identification after the
IMAC purification of the library protein.
Comprehensive N-terminal and C-terminal truncation libraries
were generated using an exonuclease III and mung bean nuclease
protocol (Fig. 1A) by cutting the pair of restriction sites at the end
of the insert to be truncated. The library was divided into sub-
libraries by size selection on agarose gel that were treated
independently, thereby separating potentially dominant small
fragments from less well expressing, but perhaps more interesting
larger constructs in the subsequent screening step. Colony PCR
and DNA sequencing of inserts from recovered clones after
ligation and transformation demonstrated an even distribution of
construct sizes (Fig. 1B). These sub-libraries were then used to
transform E. coli BL21 (DE3) that had been prepared as competent
cells containing the bait plasmid.
Two step screen for expression of soluble complexes
The libraries were screened using standard colony picking and
liquid handling robots in a work flow designed to identify any
forms of the soluble library targets and, where found, determine
CoESPRIT: A Method for Protein Complex Expression
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screen, the library was clonally separated by colony picking and
gridded on to nitrocellulose membranes according to the ESPRIT
method for single proteins [27,28]. In total, 9,216 transformant
colonies from each library were isolated representing an
approximate four-fold oversampling of constructs calculated from
the length of the gene (2,277 bp) and the frequency of truncated
inserts. The exonuclease protocol for generating inserts is therefore
able to generate many times more constructs than would be
possible using a classic PCR cloning strategy, but requires the
extra step of colony picking to isolate individual clones. Using a
solid pin arrayer, the sub-libraries were printed as inocula onto
nitrocellulose membranes over agar to generate colony arrays
where protein expression was induced by transfer of membranes to
IPTG-containing inducing agar. The colonies were lysed in situ
using sodium hydroxide soaked filter paper that denatures all the
cellular proteins and adsorbs them to the membrane [44]. These
were then hybridised with fluorescent conjugates of streptavidin
against the C-terminal biotin acceptor peptide, and a secondary
antibody recognising the anti-hexahistidine monoclonal antibody
against the N-terminal affinity tag.
Figure 1. Synthesis of incremental truncation libraries of the
PB2 gene for complex screening. (A) Plasmid DNA containing a
precloned PB2 gene insert is linearised with a pair of restriction
enzymes: one that produces an exonuclease III resistant 39 overhang
(AatII or NsiI), the other a 59 overhang which is as substrate for
exonuclease III (AscIo rNotI). A time course digestion is performed to
produce a set of evenly truncated constructs. Mung bean nuclease and
Pfu polymerase are then used to generate blunt ligatable ends; (B) DNA
fragments are separated by agarose gel electrophoresis and excised in
three size ranges. After ligation, the sublibraries are recovered by
transformation of E. coli and insert size assessed by colony PCR with
flanking primers. Pooled plasmid DNA is then used to transform an
expression strain that co-expresses the bait protein.
doi:10.1371/journal.pone.0016261.g001
Figure 2. Process of screening for soluble protein complexes
from truncation libraries. 9,216 colonies were picked for each library
and gridded onto nitrocellulose membranes over agar to generate
colony arrays in which protein expression was induced. Expression
levels and putative solubility were assessed by intensity of PB2 N-
terminal hexahistidine tag (green) and C-terminal biotinylated biotin
acceptor peptide (red) signals respectively on the colony blot. The 96
highest ranked clones were expressed in 4 ml liquid expression
cultures, purified by Ni
2+NTA affinity chromatography and eluted
fractions analysed by western blot to identify bait FLAG tag (blue) and
PB2 biotinylation signals (red). From these data, a panel of clones was
selected for 30 ml scale expression tests, then further prioritised for
larger scale production.
doi:10.1371/journal.pone.0016261.g002
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extracted from arrays and their distribution determined. The weak
background biotinylation signal observed for all colonies is a
consequence of the endogenous biotinylated protein BCCP [45]
and is useful for guiding the array fitting software. To obtain a list
of putative solubly expressing clones for further investigation in the
second liquid expression and purification step of the procedure,
only colonies exhibiting visible hexahistidine tag signals were
selected, thus eliminating truncated or degraded protein products
that, even if soluble, would not be purifiable (Fig. 2). Based upon
this, the most intense 96 positive clones with significantly higher
biotinylation signals than background were extracted from the
large bank of clones (Fig. S2). Ranking of clones for their in vivo
biotinylation efficiency permits enrichment of a population of
soluble expression clones from the library since soluble constructs
(where they exist) are generally better substrates for this
cytoplasmic post translation modification than degraded or
insoluble targets, and therefore appear higher in the ranking list.
However, the desired solubility phenotype itself is imperfect: in
some cases the identified clones may express completely solubly
[27], but we have often observed that some of the best constructs
found for challenging targets show a mixed phenotype with
expressed material in both insoluble and soluble fractions with the
latter the minor component [38]. Scale up of partially soluble
ESPRIT hits to larger culture volumes [38] or lysis buffer and
strain optimisation [46] can overcome these problems to yield
sufficient quantities for downstream studies.
A summary of the processing of each library showing the
number of clones passing through each step is presented in Fig. S3.
Ninety-six of the most intensely biotinylated, hexahistidine-positive
clones from each of the four libraries were grown in 4 ml volumes
and protein expression induced. After robot assisted purification in
96 well filter plates charged with Ni
2+NTA agarose [19], purified
fractions were obtained by elution in imidazole buffer. Since only
the PB2 constructs carry an N-terminal hexahistidine tag,
retention of the bait protein on the Ni
2+NTA affinity column
depends on its interaction with this target. Complex formation was
determined using a combined streptavidin and anti-FLAG
antibody western blot to confirm the presence of the soluble
target protein and co-purifying bait respectively.
For both the PB2 C-terminal truncation library screened against
PB1-(676–757) and the PB2 N-terminal truncation library
screened against importin a1, most constructs generated purified
PB2-bait complexes strongly visible by streptavidin-western blot of
the purified fractions (74 and 95% respectively; Fig. S3). This was
due both to an abundance of soluble solutions and also the 3-fold
oversampling resulting in many PB2 constructs of similar sizes. For
both libraries, only a subset of the hits were processed further
through medium scale purification and constructs representing
different sizes were prioritised over similar sized hits. Of this set of
clones, those with strongest biotinylation signals during colony
screening were also the best ones during the subsequent liquid
culture testing (Fig. 3). Thus, although protein expression in colony
and liquid states might be expected to differ, the approach of
ranking the former to predict the latter therefore seems effective
and provides a useful indicator of the amount of soluble protein
likely to be produced downstream.
By contrast, when the PB2 C-terminal truncation library was
screened against alternative PB1 fragments (576–757; 586–696) only
faint PB2 bands were observed by streptavidin-western blot after Ni
2+
NTA purifications under identical fluorescent scanner parameters,
with no evidence of complexes. Eight and four clones respectively
were selected for medium scale purification studies (Fig. S3) but
yielded no purified material; these libraries were not studied further.
Medium scale purification of complexes
From the PB2 N-terminal truncation library co-expressed with
importin a1, fifteen clones exhibiting complexes were retested in
30 ml cultures in 100 ml shake flasks with purification on identical
Ni
2+NTA agarose resin in a gravity column format (Fig. S3). Nine
gave visible bands by SDS-PAGE with six identified as forming
good quality stable and soluble protein complexes with importin
a1 (Fig. 4A). Strong bands were obtained for both target and bait
with similar intensities. The expression levels and purification
protocols were not individually optimized at this stage so some
E. coli contaminant proteins common to all purifications
independent of bait or PB2 region were observed. The common
band at 27 kDa, is likely the nickel-binding E. coli protein SlyD
[47] since its binding was greatly reduced when using Co
2+ affinity
resin (data not shown), as previously reported [48]. Some minor
proteolysis of the PB2 target was also observed: Constructs
PB2(C)-1A (Fig. 4A) and PB2(N)-10A (Fig. 4B) appear partially
degraded in the C-terminal region, the former having been
described previously in the NLS region [39]. Yields were estimated
at 4 mg per liter of culture which would be sufficient for structural
studies. Inserts from the positive clones were sequenced to identify
the truncation boundaries (Fig. 5). The soluble PB2 hits contained
either the NLS domain (amino acids 678–759) [27] or larger 627-
NLS double domain (amino acids 538–759) [39] that have both
been shown previously to form complexes with separately purified
importins upon mixing. One interesting exception was a very short
construct (amino acids 735–759) that corresponds precisely the
linear bipartite NLS peptide motif alone, the minimal set of amino
acids for importin binding [27]. An early objective had been to
determine whether co-expression of importin a1 would stabilise
longer PB2 constructs containing the previously characterised
interacting regions plus the crystallised upstream cap binding
domain (amino acids 317–484; Fig. 5) [37]. No such clones were
observed in agreement with the negative results obtained when
these two regions were combined in a standard cloning strategy
and expressed in the absence of importin a1 (data not shown).
From the PB2 C-terminal truncation library co-expressed with
PB1-(676–757), 22 clones were selected for scale up (Fig. S3). Of
Figure 3. Colony signals and subsequent 4 ml purification test
of highest ranking biotinylated clones. After colony screening, the
clones exhibiting the strongest signals of biotinylation for each library,
PB2(N)-1A and PB2(C)-1A, were also the best ones during the
subsequent liquid culture testing. PB2 fragments are marked with a
black diamond and the bait protein, PB1 (amino acids 676–757) or
importin a1, with a black circle.
doi:10.1371/journal.pone.0016261.g003
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six highest yielding are shown (Fig. 4B). By SDS-PAGE, bands of
similar intensities were obtained indicating that the yield and
complex qualitywould be potentially sufficient for structural studies.
This PB1 fragment used as bait was identified previously using
ESPRIT from a PB1 N-terminal truncation library and, although
purifiable at low yields, was shown to be unstructured by NMR
(data not shown). It is similar to a helical region characterised
structurally as PB2 binding [43,49]. Alignment of different PB1-
binding fragments of PB2 (Fig. 5) revealed the minimal interacting
region to be less than 40 amino acids, reflecting the ordered residues
observed in the recently crystallised PB1–PB2 interaction region
[43]. When these PB2 sub-constructs were expressed independently
of the PB1 bait, five were totally insoluble as shown for clone 2C
(Fig. 6A). The shortest peptide-sized PB2 construct (amino acids 1–
33)wassoluble;itsshort lengthmaypermitittoevadehostproteases
whilst it contains no hydrophobic core [43]. These data show that
the formation of the PB2–PB1 complex stabilises PB2 when
expressed in E. coli (Fig. 6A). In contrast, all the PB2 C-terminal
constructs were soluble both in the presence and absence of
importin a1 (Fig. 6A). Thus the complexes obtained by screening
libraries of PB2 against these two different baits represent two
common types of protein complexes (Fig. 6B): the PB1 C-terminal
and PB2 N-terminal regions forms an inter-folded and stable
structure while the PB2 C-terminal region and importin a1d o c k
together as pre-folded subunits.
Discussion
Here we describe CoESPRIT, a library scale construct
screening methodology that incorporates co-expression of bait
proteins into our previously reported protocol for identifying
soluble sub-constructs of a target protein [27,28]. It allows
identification of protein domains or fragments that interact with
a fixed bait protein and is therefore similar in concept to deletion
analyses by yeast-2-hybrid screening, but with the important
Figure 4. Co-expression and co-purification of PB2 protein complexes. Purified complexes from 4 ml expression trials with western blot
confirmation of protein identities for (A) importin a1 bait screened against PB2 N-terminal truncation libraries and (B) PB1 (amino acids 676–757) bait
against PB2 C-terminal truncation libraries. Results are presented for the six best clones from each library. Annotations are: M, molecular weight
marker; S, SDS-PAGE gel; W, western blot. Purified proteins were stained with Coomassie blue after SDS-PAGE. For western blots, bait proteins were
detected by anti-FLAG monoclonal antibody with bands in red (black circle). PB2 library proteins were detected by streptavidin binding and are green
(black diamond). Numbers in parentheses are the amino acids of the PB2 library protein.
doi:10.1371/journal.pone.0016261.g004
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downstream studies such as crystallisation, NMR, biophysical
methods (e.g. small angle X-ray scattering, analytical ultracentri-
fugation), as well as recombinant vaccine testing, that require
multi-milligram quantities of material. Additionally, the E. coli host
provides the option of labelling proteins with isotopes or heavy
atoms as needed that is less straightforward with other organisms.
Compatible plasmids were designed that permitted screening of
the library of constructs in a strain prepared as competent cells co-
expressing the bait. The first colony screening step identifies
putatively soluble forms of the target that may or may not complex
with the bait. As recently described [28], simultaneous analysis of
fused N- and C-terminal peptide tags from colony signals of a
truncated target provides a means to eliminate the out-of-frame
constructs that are a majority species in DNA truncation libraries,
together with in-frame gene products that are post-translationally
degraded. A second step of purification screening of initial
positives confirms the soluble phenotype of the target, and
identifies library members that co-purify with the bait (Fig. 2).
The main advantages of this approach are that expression of
unsuspected or difficult-to-predict domains can be achieved
without prior knowledge of the domain content of the target,
and that folding-upon-binding effects can stabilise fragile or
otherwise insoluble constructs where complex formation is
required to form a hydrophobic core and protect the target from
aggregation or proteolysis.
A standard and convenient screening capacity is approximately
27,648 clones that occupies seventy-two 384 well plates; this can
be picked in two days and then arrayed onto a single membrane
for expression screening. Such a capacity can be used to screen a
library of a single target with high oversampling for unidirection-
ally truncated genes, or with about 5% coverage of total diversity
for inserts truncated at both ends simultaneously [30]. Here we
constructed two unidirectional truncation libraries (PB2 N-
terminal and C-terminal truncation libraries) and screened them
against 4 different baits, in parallel on the same membrane. At this
level of sampling it would not be feasible to screen a target library
against a bait library since the diversity of clones in such an
experiment (tens of millions) would greatly exceed the screening
capacity of the automation. However, a sparser sampling of both
constructs randomised simultaneously might in some cases allow
direct identification of complexes that could be further refined by
subsequent steps of rescreening individually, or by limited
proteolysis and mass spectrometry depending on the requirements
of the downstream application. In a first step in this direction, we
have demonstrated how a library-based screening strategy can
permit identification of an optimal form of the bait protein
amongst several similar candidates as shown by screening one PB2
library against three different PB1 fragments where only one of the
latter proved competent for complex formation. Such coverage of
construct diversity would be practically impossible using classic
PCR cloning strategies due to issues of clone handling and cost of
reagents. Here it is a relatively simple procedure because all
constructs of a target are made in a single reaction tube and
plasmid molecules clonally separated by bacterial transformation
and robotic colony picking.
As a test case, we analysed truncation libraries of the influenza
polymerase PB2 subunit where our earlier ESPRIT protocol had
Figure 5. Alignment of PB2 constructs that co-purify with either PB1-(676–757) or importin a1. Constructs are aligned against the full-
length PB2 polypeptide sequence with amino acid numbering shown. Indicated (+) are the yields of complex as assessed by Coomassie staining of
SDS-PAGE gels shown in Fig. 4. Presented above are the known structural domains within PB2: the 627-NLS domain (PDB: 2vy6), cap-binding domain
(PDB: 2vqz) and N-terminal PB1-binding domain (PDB: 2ztt; shown minus PB1 chain).
doi:10.1371/journal.pone.0016261.g005
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structural analyses [27,37,39]. Besides providing biologically
interesting examples of co-folded and pre-folded subunits, an
additional aim was to see whether previously uncharacterised
constructs could be identified through expression of validated,
potentially stabilising partners. The N terminus of PB2 has been
shown recently by X-ray crystallography to co-fold with the C
terminus of PB1 [43] whilst the C terminus contains a small
domain that supports a NLS that has been shown, also by X-ray
crystallography, to bind tightly to importin a nuclear import
receptors (Fig. 5) [27,39].
Investigations into the domain structures of the influenza
polymerase have led to a series of new crystal structures by our
lab and others, reviewed in [41,42]. Here we have identified a series
of constructs byempiricalscreening that form stable complexes with
known partners validated recently through structural studies: PB2-
importin a [27] and PB1–PB2 [43]. The availability of these
structural data permits us to rationalise the results of the screen and
the second step of re-expression of hits minus bait protein. Of the
PB1–PB2 complexes identified, the smallest PB1-(amino acids 676–
757)-PB2-(amino acids 1–33) is similar to the ordered residues in a
recent crystal structure that shows the two polypeptides to
intertwine, forming a structural module (Fig. 6) [43]. When
expressing the subunits separately, the stability of the constructs is
severely compromised. In contrast, the C-terminal PB2 constructs
can be expressed in the absence of the importin a1 bait with no loss
of solubility, consistent with their structural independence and
previous studies showing that the proteins can be produced
separately and complexes constituted by mixing (Fig. 6).
In summary, CoESPRIT is an efficient method for identification of
purifiable soluble complexes at yields compatible with downstream
studies. Interacting polypeptides are identified from small scale
screening that, following scale up, should be validated by size
exclusion chromatography or other biophysical techniques. They can
be used directly in some applications (e.g. biophysical analyses or
immunisation), or may require further refinement including limited
proteolysis to remove unstructured regions, or tag removal prior to
crystallisation trials. However these are standard procedures that are
greatly facilitated by the availability of purified complexes as starting
material. CoESPRIT, in common with other library methods
including our original method employs the principles of directed
evolution whereby a target gene encoding a poorly expressed target is
incrementally truncated to generate random genetic diversity. Rare
clones with improved solubility characteristics and able to form stable
complexes with a co-expressed bait are isolated from the random
library using a high-throughput, automated screening workflow
based upon commonly accessible robotic systems. The level of
coverage of construct diversity far exceeds that of standard high
throughput cloning strategies and has particular advantages when the
information on the target does not permit design of expression
constructs. Although this method was designed to identify stable
binary protein complexes, analysis of multiple subunit complexes
could easily be achieved by combining the library vector with systems
for simultaneous expression of several other subunits e.g. the multi-
cassette ACEMBL system [50], the multi-plasmid pET-DUET
system (Novagen) or polycistronic pST44 [51,52]. Additionally, other
types of partner such as chaperones for enhancing protein folding or
modifyingenzymessuchasphosphataseandkinasescanbe expressed
from the bait vector and will provide additional tools for challenging,
difficult-to-express proteins.
Materials and Methods
Generation of plasmids for PB2 library construction
The PB2 gene from influenza virus strain A/Victoria/3/
1975(H3N2) [53] was codon-optimised for expression in E. coli
(Geneart, Regensburg, Germany) [27] and amplified using
primers PB2-Synth-For3: 59-GAGAT ATACA TATGG GCCAC
CATCA TCACC ACCAT GATTA TGATA TTCCA ACTAC
CGAGA-39 and PB2-Rev: 59- CCATT GTTCG ATGCA
TTATT AATCG CCATA CGAAT ACGTT TGGTC GCGGT
C-39. The product was cloned into pYUM6002, a pET9a
derivative from which non-essential DNA had been deleted, to
give plasmid pYAN008 for N-terminal truncation (59 DNA
deletion) library construction (Fig. S1A). Similarly, the PB2 gene
was amplified using PB2-For: 59-CTAGG ACGTC GATGG
AACGC ATTAA AGAAC TGCGC AACCT G-39 and PB2-
Synth-Rev3: 59- CCCGT TCATT ATTCG TGCCA TTCGA
TTTTC TGAGC CTCGA AGATG TCGTT CAGCC
CACCG-39 and cloned into alternative restriction sites of
pYUM6002 to give plasmid pYAN009 for C-terminal truncation
(39 DNA deletion) library construction (Fig. S1A). E. coli Mach1
T1 cells (Invitrogen, Carlsbad, CA, USA) were used for efficient
recovery of ligation products. Enzymes were purchased from New
England Biolabs (Beverly, MA, USA) with primers synthesised by
Invitrogen.
Generation of plasmids for bait protein expression
The gene encoding E. coli codon optimised importin a1H u
Imp-a1 [KPNA2; Uniprot: P52292, residues 60–529] (Geneart,
Figure 6. Formation of complexes of bait proteins and PB2
constructs. (A) PB2 N-terminal constructs are only soluble when co-
expressed with a PB1 C-terminal fragment (amino acids 676–757), but
insoluble when expressed independently (left); PB2 C-terminal con-
structs are soluble both when co-expressed with importin a1o r
expressed independently (right). Annotations: T, total cell lysate; P,
purified target protein. (B) Models for two types of protein complexes:
PB1 C-terminal and PB2 N-terminal regions typify complexes generated
from co-folded subunits (left); PB2 C-terminal regions and importin a1
associate as independently stable, pre-folded subunits (right).
doi:10.1371/journal.pone.0016261.g006
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forward primers FLAG-TEV-For1: 59-GGAAT TCCAT
ATGGG CGACT ACAAG GACGA CGATG ACAAG GATTA
TGATA TTCC-39, and FLAG-For2: 59-CAAGG ACGAC
GATGA CAAGG ATTAT GATAT TCCAA CTACC GAGAA
TTTGT ATTTT CAGG-39 with reverse primer importin-Rev1:
59-ATAAG AATGC GGCCG CTCAT TAAAA ATTAA
AGGTG CCCGG CGCAC CATCC-39 to add an N-terminal
FLAG tag peptide (DYKDDDDK) before the bait protein. The
importin a1 gene was cloned into NdeI/NotI sites of the vector
pLIC-SGC1 that is a pACYC184 derivative expressing rare E. coli
tRNA genes into which a T7 expression cassette had been inserted
(Structural Genomics Consortium, Toronto, Canada), forming
plasmid pYAN010 (Fig. S1B). E. coli BL21 (DE3) cells were
transformed with pYAN010, cultured in LB with chloramphenicol
30 mg/ml and used to prepare electrocompetent cells. The DNA
fragments encoding PB1 C-terminal sub-constructs corresponding
to amino acid sequences 586–696, 676–757 and 576–757
(Uniprot: 31341) were amplified by PCR, and cloned in the same
way to generate plasmids pYAN011, pYAN012 and pYAN013
containing FLAG tagged PB1 bait proteins.
Construction of PB2 random truncation libraries
A protocol using exonuclease III and mung bean nuclease was
employed to construct incremental truncation libraries using a
modification of a previously described protocol [27]. High quality
plasmid was first prepared from 200 ml overnight culture of cells
by standard alkaline lysis and phenol-chloroform extraction
protocols, then further purified using a miniprep Kit (Qiagen,
Valencia, USA). Ten micrograms of plasmid pYAN008 were
digested to completion with AatII (yielding an exonuclease III
insensitive end adjacent to the promoter) and AscI (yielding an
exonuclease sensitive end adjacent to the gene insert), both sites
being located upstream of the target gene. Four micrograms of
purified, linearised plasmid were incubated in reaction buffer (16
Buffer 1 New England Biolabs supplemented with 30 mM NaCl)
and 400 U of exonuclease III, in a final volume of 120 mla t2 2 uC.
To ensure even fragment distribution, 0.5 ml of the reaction was
removed every 30 s over 2 h and pooled in a tube containing
200 ml of 3 M NaCl on ice. The quenched reaction was denatured
at 70uC for 20 min and DNA was purified using Nucleospin
Extract II kit (Macherey-Nagel, Du ¨ren, Germany). In order to
remove the 59 overhang after exonuclease III digestion, the DNA
was incubated with 5 U of mung bean nuclease in a final volume
of 55 mla t3 0 uC for 30 min, then purified with the Nucleospin
Extract II kit. The ends of the DNA molecules were polished by
incubation with Pfu polymerase (Stratagene) in a final volume of
50 ml( 1 6Pfu polymerase native buffer, 2.5 mM dNTPs and 5 U of
enzyme) at 72uC for 20 min. Then the reaction was electropho-
resed in a 0.5% agarose gel and slices of gel containing linearised
plasmid with inserts of size 0–700, 700–1400 and 1400–2100 bp
were excised. DNA fragments were recovered from the gel using
QIAEXII resin (Qiagen) and re-circularised using T4 DNA
Ligation Kit (Roche, Mannheim, Germany); these were then used
to transform E. coli Mach1 T1 competent cells (Invitrogen).
Transformation mixes were recovered in SOC medium and plated
on LB agar (supplemented with kanamycin 50 mg/ml) in 22 cm
QTrays (Genetix, UK). After overnight growth at 37uC,
approximately 4.0610
4 colonies for each sub-library were scraped
from the agar respectively, then resuspended in phosphate
buffered saline (PBS) buffer. The plasmid DNA mixture was
extracted from the cell pellets using a miniprep kit.
A comprehensive random PB2 C-terminal truncation library
was constructed using an almost identical approach, but differing
in cleavage of pYAN009 with NsiI and NotI located at the 39 end of
the PB2 gene insert that had been cloned in frame with a 59
sequence encoding N-terminal TEV-cleavable hexahistidine tag.
Approximately 5610
4 colonies for each sub-library were plated
and pooled for DNA extraction.
Preparation of colony arrays for expression screening
Competent cells were prepared of E. coli BL21 (DE3)
harbouring pYAN010 FLAG-bait expression vectors and trans-
formed with target sub-libraries. The libraries were plated on
22 cm LB agar QTrays (supplemented with kanamycin and
chloramphenicol) at a density of approximately 3,000 colonies per
plate, and incubated overnight at 30uC. Then totally 9,216
colonies from both PB2 N-terminal and C-terminal truncation
libraries were isolated using a colony-picking robot (KBiosystems,
Basildon, UK) into 384 well plates containing 70 ml TB medium
per well (supplemented with kanamycin and chloramphenicol).
Liquid cultures were grown overnight at 37uC in a HiGro shaker
incubator (Genomic Solutions, Harvard, USA), and then all clones
of each library were arrayed robotically onto a nitrocellulose
membrane (Amersham, Arlington Heights, USA) on LB agar
plates supplemented with antibiotics. Plates were incubated
overnight at 25uC until colonies on the membrane were just
visible. Then the membrane was carefully moved onto a fresh LB
agar plate (supplemented with antibiotics, 0.1 mM IPTG and
50 mM biotin) to induce recombinant protein expression within
the colonies at 30uC for 4 h. In the same way, plasmid DNAs
extracted from PB2 C-terminal truncation sub-libraries were
transformed into E. coli BL21 (DE3) stains harbouring pYAN011,
pYAN012 and pYAN013 and processed as above.
Identification of putative soluble protein-expressing
clones
Membranes were incubated for 4 h at 30uC, lifted from the
inducing agar and laid over filter paper soaked in denaturing
buffer (0.5 M NaOH, 1.5 M NaCl) for 10 min at room
temperature. The membranes were neutralised 265 min in
neutralisation buffer (1 M Tris-HCl, pH 7.5, 1.5 M NaCl) and
then for 15 min in 26SSC buffer [44]. The cellular debris of
colonies on the membrane were carefully removed with a glass
spreader, and the membrane was blocked overnight in Superblock
(Pierce, Chicago, USA) at 4uC. The membranes were washed 3
times with PBS-T (PBS with 0.05% Tween 20) buffer for 5 min
each, and incubated in 50 ml of PBS-T containing 16 ml anti-
hexahistidine antibody (Amersham) for 1 h at 4uC. After washing
with PBS-T buffer, the membranes were further incubated in
50 ml of PBS-T containing 10 ml streptavidin Alexa Fluor 488
(Invitrogen) and 50 ml Alexa Fluor 532 goat anti-mouse IgG
(Invitrogen) for 1 h. After washing with PBS-T buffer, the
membranes were scanned with a Typhoon 9400 fluorescence
imager (Amersham) for hexahistidine tag and biotin acceptor
peptide signal intensities respectively. Signals from the array were
quantified from digitised images using Visual Grid software (GPC
Biotech, Waltham, USA) and data exported to Microsoft Excel for
analysis. Clones were sorted according to hexahistidine signals and
those exhibiting no clear signal were eliminated from further
analyses. Those that remained were ranked according to their
biotinylation signals in order to identify putatively soluble clones.
High-throughput screening of co-expressed and
co-purified protein complexes
The most intensely biotinylated 96 clones from each library
were selected for small-scale protein expression at 4 ml scale in 24
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chloramphenicol. After the cultures reached OD600=0.8, 0.1 mM
IPTG and 50 mM biotin were added to induce protein expression
and enhance protein biotinylation respectively. After overnight
induction at 25uC, the cells were pelleted by centrifugation, and
resuspended in 4 ml of sphaeroplast buffer (20 mM Tris pH 8.0,
140 mM NaCl, 20% sucrose and 1 mg/ml lysozyme). The
sphaeroplasted cells were harvested by centrifugation and then
resuspended in 800 ml lysis solution per well containing 10 mM
Tris pH 7.5, 0.5% Brij, 0.25 U/ml Benzonase (Novagen, San
Diego, USA) and 0.8 ml Protease Inhibitor Cocktail (Sigma, Saint
Louis, USA). Ninety-six protein samples were simultaneously
purified on a liquid handling robot [33] with samples loaded into a
96 well filter plate supplemented with 60 mlN i
2+NTA agarose
(Qiagen) in each well and mixed by rotation at 4uC for 30 min.
The samples were then washed with washing buffer (50 mM
phosphate buffer, pH 7, 140 mM NaCl, 5 mM imidazole) and
eluted with elution buffer (50 mM phosphate buffer, pH 7,
140 mM NaCl, 300 mM imidazole). The 96 samples were
subjected to SDS–PAGE, and then electroblotted onto a
nitrocellulose membrane. The membrane was first probed with
a 1:1000 dilution of a rabbit anti-FLAG antibody (Sigma) and then
after a wash step, incubated with a mix of a 1:1000 dilution of anti-
rabbit IgG 633 (Invitrogen) and 1:1000 dilution of Streptavidin
488. After washing with PBS-T, the membrane was scanned using
a fluorescence imager to analyse FLAG and biotin acceptor
peptide signals.
Scale-up expression and purification of selected clones
Plasmids were purified from the clones identified as soluble co-
expression hits, and the DNA inserts characterised by sequencing
to identify domain boundaries. The positive clones were grown at
37uC in 30 ml of TB media supplemented with kanamycin and
chloramphenicol. At OD600=0.8, 0.1 mM IPTG and 50 mM
biotin were added. After induction at 20uC overnight at 100 rpm,
the cells were harvested by centrifugation and 1 g of each cell
pellet was resuspended in 2 ml of resuspension solution containing
50 mM phosphate buffer, pH 7.0, 0.25 U/ml Benzonase and 2 ml
Protease Inhibitor Cocktail (Roche) and lysed by sonication. After
centrifugation, the supernatant was collected and loaded into
columns supplemented with 100 mlN i
2+NTA resin, washed
(50 mM phosphate buffer, pH 7.0, 140 mM NaCl, 50 mM
imidazole), and eluted (50 mM phosphate buffer, pH 7.0,
140 mM NaCl, 300 mM imidazole) to obtain proteins that were
analysed by SDS–PAGE.
Supporting Information
Figure S1 Schematic representation of plasmids used
for truncation library construction and soluble complex
screening. (A) Plasmids designed for library construction
(pYAN008 and pYAN009). The plasmid pYAN008 has restriction
sites (AatII and AscI) designed for creating incremental truncation
libraries from the 59 end of the target gene; a hexahistidine tag site
and a TEV protease cleavage site precede PB2 out-of-frame, and a
biotin acceptor peptide sequence is fused in-frame downstream.
For plasmid pYAN009 used for creating incremental truncation
libraries from the 39 end of the target gene, NotI and NsiI sites are
positioned downstream of the gene insert which is fused in-frame
with a hexahistidine tag and TEV protease cleavage site.
Downstream of the insert is a biotin acceptor peptide that is out
of frame with the gene. For both plasmids, a short sequence of
DNA separates restriction enzymes and a different reading frame
prevents read through from the tag sequence into the gene (…//
…). (B) The plasmid used for bait protein expression as fusions
with a TEV protease cleavable N-terminal FLAG tag. The ileX,
argU, and leuW genes in the plasmid encode rare E. coli tRNAs.
(DOCX)
Figure S2 Frequency histogram analysis of total bioti-
nylation signals from the subunit expression libraries.
(A) PB2 N-terminal truncation library co-expressed with importin
a1, and (B) PB2 C-terminal truncation library co-expressed with
PB1 (amino acids 676-757). The chart displays the frequency of
clones according to their streptavidin signals.The Y-axis is the
frequency and X-axis the binned signal intensities. The 96 most
intensely biotinylated clones selected for subsequent expression
tests exhibited higher signals than the background level from the
endogenous BCCP protein.
(DOCX)
Figure S3 Summary of processing of each library
through purification screening and analysis steps of
CoESPRIT. The numbers of clones passing through each step
are indicated.
(DOCX)
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